Dr. Tap on Olaratumab in Patients With Soft Tissue Sarcoma
1 意见
• 07/18/23
0
0
嵌入
William D. Tap, MD, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses the mechanism of action of olaratumumab as a treatment for patients with soft tissue sarcoma.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论